Skip to main navigation Skip to search Skip to main content

Radiosynthesis and in vivo evaluation of [125I]2-(4-iodophenethyl)-2-methylmalonic acid as a potential radiotracer for detection of apoptosis

  • Jongho Jeon
  • , Ha Eun Shim
  • , Sajid Mushtaq
  • , Jung Ae Kang
  • , You Ree Nam
  • , Seonhye Yoon
  • , Hye Rim Kim
  • , Dae Seong Choi
  • , Beom Su Jang
  • , Sang Hyun Park
  • Korea Atomic Energy Research Institute
  • University of Science and Technology UST

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The aim of this study is to synthesize 125I-labeled 2-(4-iodophenethyl)-2-methylmalonic acid ([125I]IMA) for the development of new apoptosis imaging tracer. The optimized radiolabeling procedure provided [125I]IMA with high radiochemical yield (75.5 ± 5.2 %) and radiochemical purity (>99 %) within 100 min. Specific radioactivity of [125I]IMA was 31.0 MBq/μmol. Biodistribution study of [125I]IMA was carried out using ICR mouse and the result showed the uptake values in apoptotic cells of the testes of the male mice were 1.7–3.2 fold higher than those of leg muscle. Therefore, [125I]IMA will be a promising radiotracer for in vivo SPECT imaging of apoptotic cells.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalJournal of Radioanalytical and Nuclear Chemistry
Volume308
Issue number1
DOIs
StatePublished - 1 Apr 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • I
  • Apoptosis
  • Biodistribution
  • Radiotracer
  • SPECT/CT

Fingerprint

Dive into the research topics of 'Radiosynthesis and in vivo evaluation of [125I]2-(4-iodophenethyl)-2-methylmalonic acid as a potential radiotracer for detection of apoptosis'. Together they form a unique fingerprint.

Cite this